Fang’s team suggested that during lipopolysaccharide (LPS)-induced depression, LPS inhibited the activity and expression of AADC by increasing plasma lipopolysaccharide-binding protein (LBP), ultimately leading to depressive-like phenotypes (Fang M. et al., 2023). Here, LBP is linked to depressive symptom measurement.